Your prediction
Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Taro Pharmaceutical Industries Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | - | - | - | - | - | - | - |
| Opko Health Inc. | 4.160% | 0.738% | -3.845% | -34.407% | -7.320% | -6.910% | -75.700% |
| Amicus Therapeutics Inc. | 0.000% | 0.833% | 0.833% | 33.702% | 0.833% | -1.434% | 24.742% |
| Viatris Inc. | -0.150% | 1.581% | 24.838% | 28.097% | 28.097% | 22.682% | -10.629% |
Comments
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat